AGP Picks
View all

California Health Watch
Provided by AGP

California Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California Health Watch.

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

Press releases published on May 8, 2026

Zahn Implant Club Rebrands as Fusion Dental Implants to Reflect Expanded Vision and Patient Experience
May 8, 2026

Zahn Implant Club Rebrands as Fusion Dental Implants to Reflect Expanded Vision and Patient Experience

Indeterminate EIN Presswire
Study finds DNA carrying antibiotic resistance genes can remain functional after common lab decontamination steps
May 8, 2026

Study finds DNA carrying antibiotic resistance genes can remain functional after common lab decontamination steps

Indeterminate EIN Presswire
Clarity Family Therapy Services Expands Mental Health Support in Los Angeles
May 8, 2026

Clarity Family Therapy Services Expands Mental Health Support in Los Angeles

Indeterminate EIN Presswire
Durkin Entertainment Presents ECOLUXE 'Best Mother's Day Gifts'
May 8, 2026

Durkin Entertainment Presents ECOLUXE 'Best Mother's Day Gifts'

Indeterminate EIN Presswire
FDA Expands Approval of VYVGART and VYVGART Hytrulo to All Adults Living with Generalized Myasthenia Gravis
May 8, 2026

FDA Expands Approval of VYVGART and VYVGART Hytrulo to All Adults Living with Generalized Myasthenia Gravis

Indeterminate GlobeNewswire
China Top 3 Vacuum Homogenizer Emulsifier Mixer Manufacturer in 2026: Leading Industrial Innovation and Development
May 8, 2026

China Top 3 Vacuum Homogenizer Emulsifier Mixer Manufacturer in 2026: Leading Industrial Innovation and Development

Indeterminate EIN Presswire
argenx Announces U.S. FDA Approval Expanding VYVGART and VYVGART Hytrulo for Use in All Adult Patients Living with gMG
May 8, 2026

argenx Announces U.S. FDA Approval Expanding VYVGART and VYVGART Hytrulo for Use in All Adult Patients Living with gMG

Indeterminate GlobeNewswire
FDA Grants Seventh Approval under the National Priority Voucher Pilot Program
May 8, 2026

FDA Grants Seventh Approval under the National Priority Voucher Pilot Program

Indeterminate GlobeNewswire
Premier Health Announces Termination of Forbearance Agreements With Principal Lenders and the Continuance of Its Strategic Review Process
May 8, 2026

Premier Health Announces Termination of Forbearance Agreements With Principal Lenders and the Continuance of Its Strategic Review Process

Indeterminate GlobeNewswire
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 8, 2026

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
MiNK Therapeutics to Report First Quarter 2026 Financial Results and Highlight Platform Progress Across iNKT Cell Therapy Programs
May 8, 2026

MiNK Therapeutics to Report First Quarter 2026 Financial Results and Highlight Platform Progress Across iNKT Cell Therapy Programs

Indeterminate GlobeNewswire
Azalea Therapeutics Announces Late-Breaking Oral Presentation at ASGCT Annual Meeting Demonstrating First-in-Primate In Vivo TRAC-CAR T Cell Engineering
May 8, 2026

Azalea Therapeutics Announces Late-Breaking Oral Presentation at ASGCT Annual Meeting Demonstrating First-in-Primate In Vivo TRAC-CAR T Cell Engineering

Indeterminate GlobeNewswire
FDA Issues Guidance to Improve Collection of Pregnancy Safety Data for Drugs and Biologics
May 8, 2026

FDA Issues Guidance to Improve Collection of Pregnancy Safety Data for Drugs and Biologics

Indeterminate GlobeNewswire
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
May 8, 2026

vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Invitation to attend the annual and the extraordinary shareholders’ meetings of the Company to be held on June 10, 2026
May 8, 2026

Invitation to attend the annual and the extraordinary shareholders’ meetings of the Company to be held on June 10, 2026

Indeterminate GlobeNewswire
Invitation à assister à l'assemblée générale annuelle et extraordinaire des actionnaires de la Société qui se tiendra le 10 juin 2026
May 8, 2026

Invitation à assister à l'assemblée générale annuelle et extraordinaire des actionnaires de la Société qui se tiendra le 10 juin 2026

Indeterminate GlobeNewswire
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 8, 2026

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update
May 8, 2026

Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update

Indeterminate GlobeNewswire
Entera Announces First Quarter 2026 Financial Results and Updates Across its Oral Peptide Programs
May 8, 2026

Entera Announces First Quarter 2026 Financial Results and Updates Across its Oral Peptide Programs

Indeterminate GlobeNewswire
Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 8, 2026

Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

California Health Watch

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.